JP2016503403A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503403A5
JP2016503403A5 JP2015540765A JP2015540765A JP2016503403A5 JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5 JP 2015540765 A JP2015540765 A JP 2015540765A JP 2015540765 A JP2015540765 A JP 2015540765A JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540765A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016503403A (ja
JP6372666B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067674 external-priority patent/WO2014070979A1/en
Publication of JP2016503403A publication Critical patent/JP2016503403A/ja
Publication of JP2016503403A5 publication Critical patent/JP2016503403A5/ja
Application granted granted Critical
Publication of JP6372666B2 publication Critical patent/JP6372666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540765A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6372666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722152P 2012-11-03 2012-11-03
US61/722,152 2012-11-03
PCT/US2013/067674 WO2014070979A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2016503403A JP2016503403A (ja) 2016-02-04
JP2016503403A5 true JP2016503403A5 (enExample) 2016-12-15
JP6372666B2 JP6372666B2 (ja) 2018-08-15

Family

ID=49620281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540765A Active JP6372666B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9334249B2 (enExample)
EP (1) EP2914592B1 (enExample)
JP (1) JP6372666B2 (enExample)
WO (1) WO2014070979A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3466955T (pt) 2014-01-13 2021-01-29 Aurigene Discovery Tech Ltd Método de preparação de derivados de oxazolo[4,5-b] piridina e tiazolo[4,5-b] piridina como inibidores de irak-4 para o tratamento do cancro
AU2018242623B2 (en) 2017-03-31 2024-05-02 Aurigene Oncology Limited Compounds and compositions for treating hematological disorders
KR102697663B1 (ko) 2017-10-31 2024-08-21 쿠리스 인코퍼레이션 혈액학적 장애를 치료하기 위한 화합물 및 조성물
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物
CN111763201A (zh) * 2020-03-03 2020-10-13 中国药科大学 苯并噻唑类化合物及医药用途
CN113831301B (zh) * 2020-06-08 2023-06-06 沈阳药科大学 苯并噻唑类衍生物及其用途
CA3187651A1 (en) * 2020-07-31 2022-02-03 Eric Sorscher Cystic fibrosis transmembrane conductance regulator (cftr) modulators, pharmaceutical compositions, and uses thereof
EP4319750A4 (en) 2021-04-08 2025-02-26 Curis, Inc. COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
TR200101664T2 (tr) * 1998-12-09 2002-03-21 American Home Products Corporation Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri
SK7702001A3 (en) 1998-12-09 2002-04-04 American Home Prod Thiourea inhibitors of herpes viruses
EP1144399A3 (en) * 1998-12-09 2002-09-11 Wyeth Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
DE50204780D1 (de) 2001-04-19 2005-12-08 Bayer Healthcare Ag Arylsulfonamide als antivirale mittel
US7138420B2 (en) 2002-08-08 2006-11-21 Boehringer Ingelheim Pharmaceuticals Inc. Substituted benzimidazole compounds
DK1957461T3 (en) 2005-11-14 2016-12-19 Genentech Inc Bisamidhæmmere the hedgehog-signalling
BRPI0716560A2 (pt) * 2006-09-11 2013-10-01 Syngenta Participations Ag composto, mÉtodo para o combate e controle de insetos, Ácaros, nematàdeos ou moluscos, e, composiÇço inseticida, acaricida, nematicida ou moluscicida
WO2009011850A2 (en) * 2007-07-16 2009-01-22 Abbott Laboratories Novel therapeutic compounds
WO2010029300A1 (en) 2008-09-12 2010-03-18 Biolipox Ab Bis aromatic compounds for use in the treatment of inflammation
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
AR077033A1 (es) * 2009-06-11 2011-07-27 Hoffmann La Roche Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas

Similar Documents

Publication Publication Date Title
JP2016503403A5 (enExample)
JP2015536947A5 (enExample)
JP2016505614A5 (enExample)
JP2015500843A5 (enExample)
JP2013544860A5 (enExample)
JP2012144574A5 (enExample)
JP2015512931A5 (enExample)
JP2018135343A5 (enExample)
JP2009263394A5 (enExample)
JP2013542218A5 (enExample)
JP2013510120A5 (enExample)
JP2011518833A5 (enExample)
JP2013544276A5 (enExample)
JP2017537949A5 (enExample)
JP2016503797A5 (enExample)
JP2013537203A5 (enExample)
JP2014526533A5 (enExample)
JP2013534248A5 (enExample)
JP2016515560A5 (enExample)
JP2016510323A5 (enExample)
JP2018533593A5 (enExample)
JP2014521744A5 (enExample)
JP2011137045A5 (enExample)
JP2016531126A5 (enExample)
JP2014526554A5 (enExample)